Evidence map›Paper›PMID 39044734›Full record

ArticleCrystal growth & design2024

Profiling Novel, Multifunctional Silane-Phosphonate Consolidants for the Mitigation of Gypsum Stone Deterioration via Concerted Autocondensation/Surface Complexation Processes.

Stefania Liakaki-Stavropoulou, Argyri Moschona, Ioannis E Grammatikakis, Duane Choquesillo-Lazarte, Konstantinos D Demadis

Abstract read
In one paragraph

Article in Crystal growth & design, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Stefania Liakaki-StavropoulouCrystal Engineering, Growth and Design Laboratory, Department of Chemistry, University of Crete, Voutes Campus, Heraklion GR-71003, Crete, Greece.
Argyri MoschonaCrystal Engineering, Growth and Design Laboratory, Department of Chemistry, University of Crete, Voutes Campus, Heraklion GR-71003, Crete, Greece.
Ioannis E GrammatikakisCrystal Engineering, Growth and Design Laboratory, Department of Chemistry, University of Crete, Voutes Campus, Heraklion GR-71003, Crete, Greece.
Duane Choquesillo-LazarteLaboratorio de Estudios Cristalográficos, IACT, CSIC-Universidad de Granada, Granada 18100, Spain.ORCID https://orcid.org/0000-0002-7077-8972
Konstantinos D DemadisCrystal Engineering, Growth and Design Laboratory, Department of Chemistry, University of Crete, Voutes Campus, Heraklion GR-71003, Crete, Greece.ORCID https://orcid.org/0000-0002-0937-8769

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mineral gypsum (selenite) stones have been used extensively by ancient Cretans in the Minoan Palace of Knossos (Crete, Greece), mostly for building and ornamental purposes. Exposure of mineral gypsum to environmental stresses (temperature fluctuations, rain, air-borne pollutants, soluble salts, etc.) causes solubility-driven degradation, and loss of cohesion of the crystal aggregates, with ensuing aesthetic degradation. In this work, the efficiency of four consolidants for artificial gypsum specimens is presented and evaluated based on drilling resistance measurements [drilling resistance measuring system (DRMS)]. Two of them (commercial names RC-70 and RC-90, RC = Rhodorsil Consolidante) are alkoxysilane-based and they are considered as benchmark consolidants. The other two [3-(trihydroxysilyl)propyl methylphosphonate monosodium salt, TRIMEPHONA, and 3-(trihydroxysilyl)propylamino-diphosphonate, TRIPADIPHOS] are multifunctional consolidants because they possess a self-condensable (after hydrolysis) trihydroxysilyl [-Si(OH)

Identifiers

PMID39044734
PMCPMC11261601

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.